Cargando…

Identification of potential SARS-CoV-2 inhibitors from South African medicinal plant extracts using molecular modelling approaches

The coronavirus is a group of viruses found in animals as well as humans and have been detected since the 1960s. However, a newly identified form, SARS-CoV-2, has triggered a recent pandemic of respiratory disease now called COVID-19. There is currently no specific antiviral drug for the treatment o...

Descripción completa

Detalles Bibliográficos
Autores principales: Dwarka, Depika, Agoni, Clement, Mellem, John Jason, Soliman, Mahmoud E, Baijnath, Himansu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAAB. Published by Elsevier B.V. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437493/
https://www.ncbi.nlm.nih.gov/pubmed/32839635
http://dx.doi.org/10.1016/j.sajb.2020.07.035
_version_ 1783572636239921152
author Dwarka, Depika
Agoni, Clement
Mellem, John Jason
Soliman, Mahmoud E
Baijnath, Himansu
author_facet Dwarka, Depika
Agoni, Clement
Mellem, John Jason
Soliman, Mahmoud E
Baijnath, Himansu
author_sort Dwarka, Depika
collection PubMed
description The coronavirus is a group of viruses found in animals as well as humans and have been detected since the 1960s. However, a newly identified form, SARS-CoV-2, has triggered a recent pandemic of respiratory disease now called COVID-19. There is currently no specific antiviral drug for the treatment of this pandemic, with most treatment strategies focused on symptomatic management and supportive therapy. As such, several drug discovery efforts are ongoing for potent treatment agents, with medicinal plants gradually gaining prominence. Approximately 80% of the South African population use traditional medicines to meet their primary health care needs. The current study aimed to identify potential COVID-19 therapeutic agents from a list of 29 bioactive compounds isolated from commonly used South African medicinal plants using molecular docking and molecular dynamics. Molecular docking identified arabic acid from Acacia senegal and L-canavanine found in Sutherlandia frutescens as a potential inhibitor of SARS-CoV-2 3C-like main protease. Similarly, hypoxoside isolated from Hypoxis hemerocallidea and uzarin from Xysmalobium undulatum, were identified as a potential inhibitor of SARS-CoV-2 receptor binding domain and SARS-CoV-2 RNA-dependent polymerase. These four bioactive compounds exhibited favourable binding orientations characterized by strong molecular interactions within respective inhibitors binding pockets of the target enzymes. Molecular dynamics simulations revealed that the binding of the identified inhibitors are characterized by structural perturbations which favour the inhibitory potency of these bioactive compounds. Additionally, in silico pharmacokinetic assessment of the compounds demonstrated favourable anti-SARS-CoV-2 properties. Although not conclusive, further experimental exploration of these compounds could serve as a starting point for the discovery of novel SARS-CoV-2 therapeutic.
format Online
Article
Text
id pubmed-7437493
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher SAAB. Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-74374932020-08-20 Identification of potential SARS-CoV-2 inhibitors from South African medicinal plant extracts using molecular modelling approaches Dwarka, Depika Agoni, Clement Mellem, John Jason Soliman, Mahmoud E Baijnath, Himansu S Afr J Bot Article The coronavirus is a group of viruses found in animals as well as humans and have been detected since the 1960s. However, a newly identified form, SARS-CoV-2, has triggered a recent pandemic of respiratory disease now called COVID-19. There is currently no specific antiviral drug for the treatment of this pandemic, with most treatment strategies focused on symptomatic management and supportive therapy. As such, several drug discovery efforts are ongoing for potent treatment agents, with medicinal plants gradually gaining prominence. Approximately 80% of the South African population use traditional medicines to meet their primary health care needs. The current study aimed to identify potential COVID-19 therapeutic agents from a list of 29 bioactive compounds isolated from commonly used South African medicinal plants using molecular docking and molecular dynamics. Molecular docking identified arabic acid from Acacia senegal and L-canavanine found in Sutherlandia frutescens as a potential inhibitor of SARS-CoV-2 3C-like main protease. Similarly, hypoxoside isolated from Hypoxis hemerocallidea and uzarin from Xysmalobium undulatum, were identified as a potential inhibitor of SARS-CoV-2 receptor binding domain and SARS-CoV-2 RNA-dependent polymerase. These four bioactive compounds exhibited favourable binding orientations characterized by strong molecular interactions within respective inhibitors binding pockets of the target enzymes. Molecular dynamics simulations revealed that the binding of the identified inhibitors are characterized by structural perturbations which favour the inhibitory potency of these bioactive compounds. Additionally, in silico pharmacokinetic assessment of the compounds demonstrated favourable anti-SARS-CoV-2 properties. Although not conclusive, further experimental exploration of these compounds could serve as a starting point for the discovery of novel SARS-CoV-2 therapeutic. SAAB. Published by Elsevier B.V. 2020-09 2020-08-19 /pmc/articles/PMC7437493/ /pubmed/32839635 http://dx.doi.org/10.1016/j.sajb.2020.07.035 Text en © 2020 SAAB. Published by Elsevier B.V. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Dwarka, Depika
Agoni, Clement
Mellem, John Jason
Soliman, Mahmoud E
Baijnath, Himansu
Identification of potential SARS-CoV-2 inhibitors from South African medicinal plant extracts using molecular modelling approaches
title Identification of potential SARS-CoV-2 inhibitors from South African medicinal plant extracts using molecular modelling approaches
title_full Identification of potential SARS-CoV-2 inhibitors from South African medicinal plant extracts using molecular modelling approaches
title_fullStr Identification of potential SARS-CoV-2 inhibitors from South African medicinal plant extracts using molecular modelling approaches
title_full_unstemmed Identification of potential SARS-CoV-2 inhibitors from South African medicinal plant extracts using molecular modelling approaches
title_short Identification of potential SARS-CoV-2 inhibitors from South African medicinal plant extracts using molecular modelling approaches
title_sort identification of potential sars-cov-2 inhibitors from south african medicinal plant extracts using molecular modelling approaches
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437493/
https://www.ncbi.nlm.nih.gov/pubmed/32839635
http://dx.doi.org/10.1016/j.sajb.2020.07.035
work_keys_str_mv AT dwarkadepika identificationofpotentialsarscov2inhibitorsfromsouthafricanmedicinalplantextractsusingmolecularmodellingapproaches
AT agoniclement identificationofpotentialsarscov2inhibitorsfromsouthafricanmedicinalplantextractsusingmolecularmodellingapproaches
AT mellemjohnjason identificationofpotentialsarscov2inhibitorsfromsouthafricanmedicinalplantextractsusingmolecularmodellingapproaches
AT solimanmahmoude identificationofpotentialsarscov2inhibitorsfromsouthafricanmedicinalplantextractsusingmolecularmodellingapproaches
AT baijnathhimansu identificationofpotentialsarscov2inhibitorsfromsouthafricanmedicinalplantextractsusingmolecularmodellingapproaches